Home › Myasthenia Gravis › Virginia
Myasthenia Gravis clinical trials in Virginia
3 studies for Myasthenia Gravis are looking for participants at sites in Virginia.
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1009, Charlottesville
- Site Number - 1040, Richmond
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
- Research Site, Norfolk
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Apr 1, 2026 · NCT06607627Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- University of Virginia (UVA) Health - Developmental Pediatrics Clinic, Charlottesville
RecruitingPhase 2/3
Ages 2 to 18 · All sexes · Updated Feb 18, 2026 · NCT04833894From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.